We are live on
!
Find out more
BCM
Bayesian Capital Management Portfolio holdings
AUM
$81.9M
1-Year Est. Return
26.59%
This Fund
S&P 500
This Quarter
Est. Return
-1.32%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$493M
AUM Growth
-$43.7M
(-8.1%)
Cap. Flow
-$6.65M
Cap. Flow
% of AUM
-1.35%
Top 10 Holdings %
Top 10 Hldgs %
14.21%
Holding
1,115
New
370
Increased
135
Reduced
155
Closed
453
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$15.8M |
| 2 |
Micron Technology
MU
|
+$9.79M |
| 3 |
Medtronic
MDT
|
+$7.24M |
| 4 |
Meta Platforms (Facebook)
META
|
+$6.64M |
| 5 |
Alibaba
BABA
|
+$5.41M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Truist Financial
TFC
|
+$6.76M |
| 2 |
Qualcomm
QCOM
|
+$6.11M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$4.04M |
| 4 |
EOG Resources
EOG
|
+$4.02M |
| 5 |
T-Mobile US
TMUS
|
+$3.82M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.08% |
| 2 | Healthcare | 13.66% |
| 3 | Consumer Discretionary | 12.3% |
| 4 | Industrials | 9.83% |
| 5 | Financials | 9.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Gogo Inc
GOGO
$550M
| $188K | 0.04% |
15,545
+2,100
| +16% | +$31.9K |
|
527
Heron Therapeutics
HRTX
$92M
| $188K | 0.04% |
+44,600
| New | +$175K |
|
528
Brixmor Property Group
BRX
$9.77B
| $186K | 0.04% |
+10,072
| New | +$218K |
|
529
Enovix
ENVX
$866M
| $186K | 0.04% |
11,613
-8,571
| -42% | -$127K |
|
530
IAMGOLD
IAG
$8.24B
| $186K | 0.04% |
+174,100
| New | +$232K |
|
531
Under Armour
UAA
$3.04B
| $186K | 0.04% |
+27,931
| New | +$244K |
|
|
ESPR
532
DELISTED
Esperion Therapeutics
ESPR
| $185K | 0.04% |
+27,630
| New | +$190K |
|
|
EB
533
DELISTED
Eventbrite
EB
| $180K | 0.04% |
+29,600
| New | +$249K |
|
534
Vishay Intertechnology
VSH
$5.02B
| $180K | 0.04% |
+10,108
| New | +$197K |
|
|
GOGL
535
DELISTED
Golden Ocean Group
GOGL
| $172K | 0.03% |
23,000
+8,869
| +63% | +$88.9K |
|
536
Liberty Latin America Class C
LILAK
$1.65B
| $172K | 0.03% |
+30,690
| New | +$197K |
|
|
BRY
537
DELISTED
Berry Corp
BRY
| $171K | 0.03% |
22,772
+500
| +2% | +$4.23K |
|
|
CD
538
DELISTED
Chindata Group Holdings Limited American Depositary Shares
CD
| $171K | 0.03% |
+21,195
| New | +$163K |
|
539
Arcturus Therapeutics
ARCT
$163M
| $169K | 0.03% |
+11,399
| New | +$191K |
|
540
RPC Inc
RES
$1.14B
| $169K | 0.03% |
+24,438
| New | +$177K |
|
|
SAFE
541
Safehold
SAFE
$1.19B
| $169K | 0.03% |
+3,752
| New | +$261K |
|
542
Hims & Hers Health
HIMS
$6.79B
| $168K | 0.03% |
30,130
-27,000
| -47% | -$163K |
|
543
Stellantis
STLA
$16.7B
| $168K | 0.03% |
14,200
-58,200
| -80% | -$782K |
|
|
FLG
544
Flagstar Bank National Association
FLG
$5.83B
| $168K | 0.03% |
+6,551
| New | +$192K |
|
|
VZIO
545
DELISTED
VIZIO Holding Corp.
VZIO
| $165K | 0.03% |
+18,865
| New | +$190K |
|
546
Alight
ALIT
$523M
| $164K | 0.03% |
+1,121
| New | +$173K |
|
547
Atara Biotherapeutics
ATRA
$70.4M
| $164K | 0.03% |
+1,734
| New | +$195K |
|
548
TG Therapeutics
TGTX
$8.4B
| $164K | 0.03% |
27,625
+5,925
| +27% | +$38.9K |
|
549
Wipro
WIT
$19B
| $163K | 0.03% |
69,200
-19,400
| -22% | -$50.2K |
|
550
Arlo Technologies
ARLO
$1.55B
| $157K | 0.03% |
33,789
+15,500
| +85% | +$97.1K |
|
Similar funds
KL
FWS
FRIHG
AGFVA
1C
MP
FLC
APW
Bayesian Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Bayesian Capital Management held 1,115 positions worth $493M, down 8.1% from $537M the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Bayesian Capital Management's Q3 2022 filing shows 370 new, 135 increased, 155 reduced and 453 closed positions. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M. The largest sale was Truist Financial, an estimated $6.76M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Bayesian Capital Management's largest Q3 2022 buy was State Street SPDR S&P 500 ETF Trust: 39,700 shares worth $14.2M.
- Bayesian Capital Management added most to Medtronic in Q3 2022, an estimated $7.24M increase.
- Bayesian Capital Management's biggest Q3 2022 reduction was Truist Financial, cutting an estimated $6.76M.
- Bayesian Capital Management fully exited Walgreens Boots Alliance in Q3 2022, selling an estimated $4.04M.
- Bayesian Capital Management's ten largest holdings make up 14% of its $493M portfolio in Q3 2022.
- Bayesian Capital Management opened 370 new positions and closed 453 in Q3 2022.
- Bayesian Capital Management's portfolio value fell 8.1% quarter-over-quarter to $493M.
Based on Bayesian Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.